Carbimazole or st.post thyroidectomy, condition for graves disease

GRAVES_COND

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^BAA60 Medicine purchases: ATC — H03BB01 2 out of 7 registries used, show all original rules.	9127
4. Check minimum number of events Min. number of events 3	9127
5. Include endpoints None	9127
6. Filter based on genotype QC (FinnGen only)	9127

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF9

NAME	GRAVES_COND
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^BAA60
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	H03BB01
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Carbimazole or st.post thyroidectomy, condition for graves disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Graves disease, strict definition

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9127	7274	1853
Unadjusted period prevalence (%)	2.14	2.48	0.82
Median age at first event (years)	53.78	52.26	59.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7979: Matched controls
79788

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H03BB01

ATC

carbimazole; oral

279.7

323.0

5163

520

BAA60

NOMESCO Finland

Total thyroidectomy

+∞

323.0

4087

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

19.8

323.0

635

347

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

75.0

323.0

804

119

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

40.5

323.0

573

152

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

149.5

323.0

3621

441

104

Kela drug reimbursment

Thyroid insufficiency

17.5

323.0

3154

2879

H03AA01

ATC

levothyroxine sodium; systemic

16.3

323.0

6066

12988

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

15.1

323.0

1534

1241

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

82.9

323.0

1098

153

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

11.3

323.0

671

645

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

87.7

323.0

2609

440

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

16.7

323.0

639

413

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

103.5

323.0

1693

207

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

55.1

323.0

910

186

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

323.0

3609

17944

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

98.2

323.0

1319

161

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

105.8

323.0

918

EP1AE

NOMESCO Finland

Neck ultrasound examination

10.5

323.0

1587

1835

C07AA05

ATC

propranolol; systemic

3.4

323.0

2659

10186

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

177.2

323.0

483

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

85.1

323.0

472

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

13.2

279.3

508

409

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

93.6

275.5

306

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

13.3

259.5

470

374

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

275.7

235.8

240

T85

ICPC

Hyperthyroidism/thyrotoxicosis

35.9

233.0

304

4CJ01

NOMESCO Finland

172.9

224.2

235

C07AB07

ATC

bisoprolol; oral

2.1

220.6

3746

23269

E05.89

ICD-10 Finland

Other thyrotoxicosis

96.8

220.5

244

A11CC03

ATC

alfacalcidol; systemic

9.5

204.7

440

489

ZX114

NOMESCO Finland

Intramuscular

11.2

188.6

369

343

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

179.9

2457

13533

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

17.2

167.2

271

163

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

44.0

165.2

206

T86

ICPC

Hypothyroidism/myxoedema

4.5

162.6

617

1450

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

73.4

157.3

180

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

137.7

151.8

162

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

150.8

3119

19955

E03.89

ICD-10 Finland

Other specified hypothyroidism

4.7

149.5

540

1204

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

47.8

145.2

178

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

144.5

2036

11162

H062, E050

ICD-10 Finland

141.8

143.7

153

E83.51

ICD-10 Finland

Hypocalcemia

21.2

140.4

211

102

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

14.2

138.7

242

175

ZXA10

NOMESCO Finland

Bilateral

2.1

128.6

1657

8671

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

38.9

128.4

164

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.4

126.9

1281

5973

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

58.3

125.9

149

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

38.9

125.3

160

106

Kela drug reimbursment

Hypoparathyroidism

27.0

119.7

167

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

21.0

119.0

179

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

21.7

115.5

172

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

6.6

112.6

303

474

E03

ICD-10 Finland

Other hypothyroidism

2.9

101.3

688

2545

WX402

NOMESCO Finland

General anaesthesia

2.0

95.4

1452

8017

C01BD01

ATC

amiodarone; systemic

5.3

94.3

303

591

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

32.3

91.1

121

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

88.8

3066

21946

T71

ICPC

Malignant neoplasm thyroid

68.1

87.6

101

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

82.5

3255

23986

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

74.3

1063

5674

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.4

74.0

382

1162

A11CC02

ATC

dihydrotachysterol; oral

25.1

73.4

104

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

15.9

68.4

113

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.6

66.8

510

2012

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

83.1

66.0

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

4.6

64.3

235

527

E05.5

ICD-10 Finland

Thyroid crisis or storm

315.3

61.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

61.0

2954

22345

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.8

59.9

177

313

Z51.88

ICD-10 Finland

Other specified medical care

4.6

58.6

213

475

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

12.5

58.0

106

T81

ICPC

Goitre

12.7

57.4

104

H03BA02

ATC

propylthiouracil; oral

42.1

57.0

N02BE01

ATC

paracetamol; systemic, rectal

1.6

56.2

6657

60455

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.3

55.0

173

330

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

53.6

1177

7220

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

46.8

53.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

46.6

1410

9426

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.7

46.5

164

356

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

100.6

45.8

TFP20

NOMESCO Finland

Cardiodefibrillation

2.3

45.5

447

2009

E06.3

ICD-10 Finland

Autoimmune thyroiditis

6.4

44.6

120

189

ZXE00

NOMESCO Finland

One hour or less

1.4

42.6

2915

23129

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

5.8

42.4

123

214

E04.8

ICD-10 Finland

Other specified nontoxic goitre

11.0

42.1

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

7.1

41.5

104

149

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.6

41.3

312

1220

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

14.8

41.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

39.9

1532

10794

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

6.6

39.6

104

159

C07AB02

ATC

metoprolol; systemic

1.6

39.5

1260

8500

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

35.9

39.0

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

22.1

37.8

WX704

NOMESCO Finland

Intubation

2.0

37.6

535

2817

H05.2

ICD-10 Finland

Exophthalmic conditions

11.4

37.5

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.8

36.0

124

264

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

35.9

646

3692

CA1AD

NOMESCO Finland

Orbita CT

15.4

35.1

207

Kela drug reimbursment

Chronic arrhythmias

1.7

34.9

769

4685

H02AB06

ATC

prednisolone; systemic

1.3

33.3

3297

27466

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

3.9

33.1

138

354

E06.2

ICD-10 Finland

Chronic thyroiditis with transient thyrotoxicosis

44.6

32.7

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

32.0

2312

18279

JN5SN

NOMESCO Finland

61.9

32.0

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

11.6

31.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

31.6

1005

6739

E06.9

ICD-10 Finland

Thyroiditis, unspecified

8.3

31.3

E06.4

ICD-10 Finland

Drug-induced thyroiditis

53.1

31.3

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

31.2

729

4511

E20.8

ICD-10 Finland

Other hypoparathyroidism

22.1

30.4

Z2221

NOMESCO Finland

Medical doctor

1.4

30.0

1986

15440

R49.08

ICD-10 Finland

Other specified dysphonia

2.8

29.7

198

720

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.9

28.7

195

BA1AQ

NOMESCO Finland

Thyroid SPECT with low dose CT

150.5

28.6

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

43.9

28.6

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

16.8

28.3

B01AA03

ATC

warfarin; systemic

1.5

27.7

962

6572

J01DB01

ATC

cefalexin; oral

1.3

27.4

6097

56372

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

18.3

27.3

GB1AA

NOMESCO Finland

Tracheal X-ray examination

19.6

27.3

E04

ICD-10 Finland

Other nontoxic goitre

7.8

27.3

A12AA04

ATC

calcium carbonate; oral

3.7

27.3

121

329

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.8

27.3

193

Z3226

NOMESCO Finland

Physiotherapist

1.5

27.2

1224

8839

WZC30

NOMESCO Finland

Teaching

1.6

26.8

848

5667

C01AA05

ATC

digoxin; systemic

2.0

26.1

359

1863

R00.2

ICD-10 Finland

Palpitations

1.7

25.5

527

3143

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

25.2

293

1421

T72

ICPC

Benign neoplasm thyroid

10.5

25.2

C07AA07

ATC

sotalol; systemic

2.4

24.9

226

977

B01AB05

ATC

enoxaparin; parenteral

1.3

24.5

1975

15752

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

24.2

708

4641

WX110

NOMESCO Finland

Local anesthesy

1.3

24.1

5024

45485

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.8

24.1

156

560

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

23.9

1197

8802

BAA99

NOMESCO Finland

Other operation on thyroid gland

22.8

23.8

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

33.4

23.3

R4110

NOMESCO Finland

Physiotherapy

1.3

23.3

1704

13372

E06.1

ICD-10 Finland

Subacute thyroiditis

4.4

23.0

192

C03CA01

ATC

furosemide; systemic

1.4

22.9

1451

11116

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

22.9

312

1614

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

22.8

758

5120

Z3231

NOMESCO Finland

Registered nurse

1.3

22.8

1762

13937

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

3.4

22.7

112

333

TFP35

NOMESCO Finland

Electroanatomical mapping

3.4

22.6

110

324

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

7.3

22.6

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

7.1

22.5

A02BC02

ATC

pantoprazole; systemic

1.3

22.3

4570

41072

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

22.3

917

6485

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

21.8

939

6696

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

21.7

616

4004

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

7.6

21.5

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

21.2

320

1721

R94.6

ICD-10 Finland

Abnormal results of thyroid function studies

5.6

21.2

112

TFP34

NOMESCO Finland

Electrophysiological investigation

2.4

21.0

187

805

E8901, C7391

ICD-10 Finland

210.5

20.6

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

18.3

20.4

XF404

NOMESCO Finland

Ambulatory ECG

1.6

20.3

536

3415

GD6AD

NOMESCO Finland

CT of chest and neck

8.5

20.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

20.1

1570

12399

R03AC02

ATC

salbutamol; inhalant

1.2

20.1

3750

33139

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

17.3

20.0

CAC44

NOMESCO Finland

Combined decompression of orbit

57.6

19.9

R4130

NOMESCO Finland

Speech therapy

2.6

19.8

144

556

H50.2

ICD-10 Finland

Vertical strabismus

4.7

19.8

143

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

19.7

241

1197

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

19.5

561

3656

WW200

NOMESCO Finland

Immunization

2.3

19.4

181

795

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

5.8

19.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

18.8

1001

7419

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

9.1

18.8

BA2MN

NOMESCO Finland

Thyroid radiation dose measurement during isotope therapy

+∞

18.8

R13

ICD-10 Finland

Dysphagia

1.7

18.7

381

2261

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

18.7

287

1554

A02BC05

ATC

esomeprazole; systemic

1.3

18.6

2766

23744

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

8.7

18.3

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.0

18.2

229

1148

K80

ICPC

Cardiac arrhythmia NOS

1.6

17.9

435

2715

WA039

NOMESCO Finland

Radiotherapy with free isotopes

+∞

17.7

XX1MN

NOMESCO Finland

Isotope examination with measurement

66.7

17.7

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

3.3

17.6

272

8345/3-C73.9

ICD-O-3

Medullary thyroid carcinoma of thyroid gland

180.3

17.5

R06.0

ICD-10 Finland

Dyspnoea

1.3

17.4

1497

11964

I47.2

ICD-10 Finland

Ventricular tachycardia

2.6

17.4

128

499

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

17.3

3398

30005

WX002

NOMESCO Finland

Sedation and analgesia

1.3

17.2

1207

9352

Z50.5

ICD-10 Finland

Speech therapy

2.9

17.1

104

359

ZX120

NOMESCO Finland

Intravenous

1.5

16.8

571

3870

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

16.8

297

1689

C73.93

ICD-10 Finland

Anaplastic thyroid carcinoma (thyroid)

35.1

16.6

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

27.6

16.5

CBK00

NOMESCO Finland

Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction

40.1

16.3

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.5

16.1

130

533

C01BC04

ATC

flecainide; systemic

2.0

15.7

195

976

R53

ICD-10 Finland

Malaise and fatigue

1.3

15.7

1265

9998

CAC20

NOMESCO Finland

Lateral decompression of orbit

33.4

15.7

H53.2

ICD-10 Finland

Diplopia

2.0

15.3

191

960

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.1

15.1

165

785

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.9

15.1

327

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

15.0

1779

14784

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

14.9

268

1532

2420A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic diffuse goitre

8.9

14.9

H02AB07

ATC

prednisone; oral

1.4

14.6

893

6759

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

14.5

612

4340

J01AA02

ATC

doxycycline; systemic

1.2

14.4

5680

53362

R21

ICPC

Throat symptom/complaint

1.3

14.3

1311

10540

E07.89

ICD-10 Finland

Other specified disorders of thyroid

10.4

14.2

WX892

NOMESCO Finland

Monitored bed care

1.6

13.9

389

2522

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

13.8

291

1745

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.1

13.8

150

713

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

2.9

13.7

285

B01AF02

ATC

apixaban; oral

1.5

13.7

452

3045

K04

ICPC

Palpitations/awareness of heart

1.6

13.7

318

1961

AQ2

Electrophysiological electroanatomical examination

4.7

13.6

R49.01

ICD-10 Finland

Functional dysphonia

1.9

13.5

202

1086

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

13.5

718

5313

BA1AN

NOMESCO Finland

Thyroid gland isotope imaging

140.2

13.4

G73.0*E05.9

ICD-10 Finland

Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]

140.2

13.4

XCK00

NOMESCO Finland

Perimetry

1.6

13.4

379

2461

A04

ICPC

Weakness/tiredness general

1.4

13.3

748

5589

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

5.9

13.2

198

Kela drug reimbursment

Sorafenib

10.4

13.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

13.1

420

2806

E50.0

ICD-10 Finland

Vitamin A deficiency with conjunctival xerosis

50.1

12.8

R01AD09

ATC

mometasone; nasal

1.2

12.8

3170

28354

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

12.6

234

1352

M14.5*E05.9

ICD-10 Finland

Arthropathy in thyrotoxicosis [hyperthyroidism]

70.0

12.6

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

5.3

12.5

GAB20

NOMESCO Finland

Median sternotomy

17.3

12.5

1AB01

NOMESCO Finland

130.2

12.4

EP1AE

SPAT

2.4

12.4

104

440

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

4.7

12.4

ZSB00

NOMESCO Finland

Procedure related to previous procedure classified in chapter B

11.6

12.3

J01FA10

ATC

azithromycin; systemic

1.2

12.3

4197

38577

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

12.1

196

1086

H50.6

ICD-10 Finland

Mechanical strabismus

21.3

12.0

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

11.9

3470

31421

E05.3

ICD-10 Finland

Thyrotoxicosis from ectopic thyroid tissue

46.7

11.9

ZXA00

NOMESCO Finland

Right side

1.2

11.9

1604

13487

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

11.7

1060

8486

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

11.6

525

3771

Z01.7

ICD-10 Finland

Laboratory examination

1.4

11.5

654

4892

E06.0

ICD-10 Finland

Acute thyroiditis

6.1

11.5

2AB04

NOMESCO Finland

6.1

11.5

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

6.9

11.3

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

11.2

944

7486

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

12.7

11.1

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.8

11.1

180

1000

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

11.0

1546

13039

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

10.9

331

2188

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.8

10.7

173

958

CA1BD

NOMESCO Finland

Extensive orbita CT

10.5

10.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

10.7

2616

23258

WX320

NOMESCO Finland

Spinalanesthesy

1.2

10.7

1365

11388

A02BC01

ATC

omeprazole; systemic

1.2

10.6

1673

14270

J01FA06

ATC

roxithromycin; oral

1.2

10.6

2715

24237

K02.1

ICD-10 Finland

Caries of dentine

1.2

10.6

3892

35794

C09AA05

ATC

ramipril; oral

1.3

10.6

1188

9768

C03DA01

ATC

spironolactone; oral

1.4

10.6

513

3731

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

10.5

3799

34883

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.2

10.5

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

10.5

372

2546

ZXA05

NOMESCO Finland

Left side

1.2

10.4

1478

12468

8000/3-C73.9

ICD-O-3

Neoplasm, malignant of thyroid gland

110.1

10.4

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

7.7

10.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

10.3

2626

23410

323

Kela drug reimbursment

Sorafenib

16.0

10.3

N05CF01

ATC

zopiclone; oral

1.2

10.3

1946

16896

I50.1

ICD-10 Finland

Left ventricular failure

1.8

10.1

168

943

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

10.1

2068

18086

R07.0

ICD-10 Finland

Pain in throat

1.5

10.1

374

2586

R01AD08

ATC

fluticasone; nasal

1.2

10.1

1907

16554

J01FA09

ATC

clarithromycin; systemic

1.2

10.0

2108

18474

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

10.0

380

2642

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.5

9.9

309

B01AB04

ATC

dalteparin; parenteral

1.6

9.9

255

1619

K78

ICPC

Atrial fibrillation/flutter

1.5

9.9

309

2059

Z71.8

ICD-10 Finland

Other specified counselling

1.2

9.9

1503

12765

1508

Kela drug reimbursment

Lenvatinib

26.0

9.8

XF402

NOMESCO Finland

ECG with work load test

1.4

9.8

557

4166

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

13.4

9.6

E83.50

ICD-10 Finland

Hypercalcemia

2.4

9.6

321

S04

ICPC

Lump/swelling localized

1.4

9.6

521

3868

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

2.9

9.5

195

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

4.2

9.4

PJD99

NOMESCO Finland

Excision of other lymph nodes

7.5

9.4

N02AX02

ATC

tramadol; systemic, rectal

1.2

9.3

2595

23256

342

Kela drug reimbursment

Dronedarone

3.1

9.3

159

8290/3-C73.9

ICD-O-3

Oxyphilic adenocarcinoma of thyroid gland

21.7

9.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

9.3

2348

20878

C739

ICD-10 Finland

8.7

9.3

L01XE05

ATC

[U] sorafenib; oral

10.6

9.3

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.3

2958

26802

M79.6

ICD-10 Finland

Pain in limb

1.2

9.2

2308

20500

A60

ICPC

General and Unspecified, Result test/procedure

1.6

9.2

246

1579

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

9.2

352

2449

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

9.2

1862

16247

C08CA01

ATC

amlodipine; oral

1.2

9.2

1853

16158

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

9.1

488

3610

L28

ICPC

Limited function/disability (L)

1.3

9.1

811

6472

J02AC01

ATC

fluconazole; systemic

1.2

9.1

3068

27909

WX290

NOMESCO Finland

Other blockade of nerve

1.2

9.1

2951

26769

C03AA03

ATC

hydrochlorothiazide; oral

1.4

9.0

493

3662

1CX08

NOMESCO Finland

4.7

9.0

130

Kela drug reimbursment

Malignant tumour

1.4

9.0

353

2472

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

9.0

3017

27428

E21.0

ICD-10 Finland

Primary hyperparathyroidism

2.1

9.0

446

R02

ICPC

Shortness of breath/dyspnoea

1.3

8.9

664

5173

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

8.9

892

7221

3019

Kela drug reimbursment

Lenvatinib

24.0

8.9

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

4.0

8.9

R03BA02

ATC

budesonide; inhalant

1.2

8.7

1084

9009

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

8.6

521

3934

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.6

4639

43599

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

8.5

1840

16122

E06

ICD-10 Finland

Thyroiditis

6.9

8.5

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.0

8.5

485

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

20.0

8.5

E03.4

ICD-10 Finland

Atrophy of thyroid (acquired)

20.0

8.5

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

8.4

248

1633

R49.03

ICD-10 Finland

Atrophic dysphonia

2.6

8.4

213

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

8.4

539

4110

AA1AD

NOMESCO Finland

CT of head and brain

1.2

8.4

1241

10502

F29

ICPC

Eye symptom/complaint other

1.4

8.3

460

3426

H50.8

ICD-10 Finland

Other specified strabismus

6.7

8.3

T15

ICPC

THYROID LUMP/MASS

6.7

8.3

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

3.5

8.3

102

RL210

NOMESCO Finland

3.3

8.3

118

A10AE04

ATC

insulin glargine; parenteral

1.4

8.3

435

3214

WX720

NOMESCO Finland

Own respiration

1.6

8.2

197

1233

UDQ02

NOMESCO Finland

Direct laryngoscopy

2.7

8.2

197

RP210

NOMESCO Finland

4.7

8.2

E89.9

ICD-10 Finland

Postprocedural endocrine and metabolic disorder, unspecified

14.5

8.2

ZXB10

NOMESCO Finland

Medial

3.2

8.1

125

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

5.1

8.1

WF099

NOMESCO Finland

Other radiotherapy

3.1

8.1

131

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

8.1

995

8255

ENB50

NOMESCO Finland

Excision of cyst or fistula of thyroglossic duct

8.1

J01CA04

ATC

amoxicillin; systemic

1.2

8.1

5893

56489

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

2.8

8.0

177

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

8.0

6751

65470

A98

ICPC

Health maint/preventive medicine

1.3

8.0

7515

73764

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

8.0

355

2545

R06AE07

ATC

cetirizine; oral

1.1

8.0

3056

27977

K90.0

ICD-10 Finland

Coeliac disease

1.7

7.9

166

1005

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

7.9

411

3029

ZXE40

NOMESCO Finland

More than seven and less than nine hours

1.9

7.9

114

612

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.9

1903

16814

LCA06

NOMESCO Finland

Biopsy of endometrium

1.2

7.9

860

7037

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

7.9

749

6028

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

13.0

7.9

E06.5

ICD-10 Finland

Other chronic thyroiditis

13.0

7.9

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

7.9

331

2351

A08

ICPC

Swelling

1.6

7.9

209

1346

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

7.8

443

3312

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.4

7.8

376

2736

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

7.8

1005

8379

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

3.0

7.8

141

TBA20

NOMESCO Finland

Aspiration cytology of thyroid gland

9.4

7.8

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

7.7

232

1537

M03BX02

ATC

tizanidine; oral

1.1

7.7

4409

41455

N07BB01

ATC

disulfiram; oral

0.5

7.7

1352

R60.0

ICD-10 Finland

Localized oedema

1.3

7.6

573

4471

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

7.6

108

579

S18

ICPC

Laceration/cut

1.2

7.6

2494

22555

M02AA07

ATC

piroxicam; topical

1.2

7.6

2268

20376

BBA20

NOMESCO Finland

Exploration of parathyroid gland

3.8

7.5

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3.8

7.5

A29

ICPC

General symptom/complaint other

1.3

7.5

586

4599

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.5

2637

23961

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

7.5

749

6066

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

2.8

7.5

155

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

7.5

240

1616

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

7.5

849

6978

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.1

7.5

128

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

7.5

302

2132

J01DA01

ATC

[U] cefalexin; systemic

1.1

7.4

4348

40890

T89

ICPC

Diabetes insulin dependent

1.6

7.4

184

1167

A02BC03

ATC

lansoprazole; oral

1.2

7.4

1763

15550

R2110

NOMESCO Finland

Giving the first information

1.3

7.4

453

3435

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.5

7.4

219

1447

JN5AN

NOMESCO Finland

Total body isotope imaging

7.6

7.4

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

7.6

7.4

C75

ICD-10 Finland

Malignant neoplasm of other endocrine glands and related structures

+∞

7.3

R03BB04

ATC

tiotropium bromide; inhalant

1.3

7.3

437

3304

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

6.8

7.3

H02.5

ICD-10 Finland

Other disorders affecting eyelid function

4.9

7.3

CEC00

NOMESCO Finland

Recession of extraocular muscle

3.4

7.3

T99

ICPC

Endocr/metab/nutrit disease other

2.0

7.2

419

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.3

7.2

494

3806

O90.5

ICD-10 Finland

Postpartum thyroiditis

15.7

7.2

G47.3

ICD-10 Finland

Sleep apnoea

1.2

7.2

1077

9112

SPAT1262

SPAT

Handing over of treatment supplies

1.2

7.2

924

7699

SPAT1097

SPAT

Recording of ECG

1.2

7.2

769

6278

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.0

7.2

439

H57.1

ICD-10 Finland

Ocular pain

1.6

7.1

179

1140

J01MA02

ATC

ciprofloxacin; systemic

1.2

7.1

2241

20188

AQ1

Conventional electrophysiological examination

2.2

7.1

292

H50.0

ICD-10 Finland

Convergent concomitant strabismus

2.9

7.0

134

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

2.7

7.0

157

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

7.0

3248

30033

C09DX04

ATC

valsartan and sacubitril; oral

3.1

6.9

113

I50.0

ICD-10 Finland

Congestive heart failure

1.5

6.9

240

1644

H02AB09

ATC

hydrocortisone; systemic

1.7

6.9

121

699

L01

ICPC

Neck symptom/complaint

1.2

6.9

812

6707

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

6.8

1613

14209

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

4.8

6.8

WF002

NOMESCO Finland

Radical radiotherapy

1.6

6.8

180

1160

M01AE03

ATC

ketoprofen; systemic, rectal

1.1

6.8

2339

21195

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.3

6.8

693

5628

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.4

6.8

313

2265

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

6.8

682

5529

8010/3-C73.9

ICD-O-3

Carcinoma, NOS, of thyroid gland

40.0

6.8

BWA00

NOMESCO Finland

Repair of wound dehiscence in endocrine surgery

40.0

6.8

L01XE29

ATC

[U] lenvatinib; oral

40.0

6.8

8020/3-C73.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of thyroid gland

40.0

6.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

6.7

137

826

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

7.2

6.7

UJC01

NOMESCO Finland

Scopy of lower throat

2.4

6.7

218

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

6.7

1333

11577

ZXD20

NOMESCO Finland

Day surgery

1.2

6.7

764

6284

P01AB01

ATC

metronidazole; oral, rectal

1.1

6.7

2714

24865

SPAT1263

SPAT

Sampling

1.1

6.6

2716

24889

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

2.7

6.6

161

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

6.6

2321

21046

C01BD07

ATC

dronedarone; oral

2.9

6.6

132

BAA30

NOMESCO Finland

Excision of thyroid isthmus

5.9

6.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

6.6

4976

47387

7AX01

NOMESCO Finland

12.2

6.6

C09CA01

ATC

losartan; oral

1.2

6.5

1253

10842

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

10.0

6.5

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.6

6.5

153

957

A91

ICPC

Abnormal result investigation NOS

1.5

6.5

213

1444

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.5

1412

12355

E10

ICD-10 Finland

Type 1 diabetes mellitus

1.9

6.5

494

R06AX27

ATC

desloratadine; oral

1.2

6.5

1797

16022

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.6

6.5

167

1073

R42

ICD-10 Finland

Dizziness and giddiness

1.2

6.4

1199

10347

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.2

6.4

259

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

3.7

6.4

E05.81

ICD-10 Finland

Overproduction of thyroid-stimulating hormone

69.9

6.4

SPAT1336

SPAT

Request for examination

1.5

6.4

194

1291

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

6.4

376

2836

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

7.4

6.4

J01FF01

ATC

clindamycin; systemic

1.2

6.4

1613

14277

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

6.4

599

4819

SPAT1153

SPAT

Removal of sutures

1.2

6.4

1860

16644

N05BA04

ATC

oxazepam; oral

1.2

6.4

1518

13377

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

6.3

1090

9346

JN4AD

NOMESCO Finland

Body CT examination

1.4

6.3

349

2610

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.4

6.3

354

2650

8510/3-C73.9

ICD-O-3

Medullary carcinoma, NOS, of thyroid gland

18.0

6.3

E07

ICD-10 Finland

Other disorders of thyroid

18.0

6.3

E8901, E050

ICD-10 Finland

+∞

6.2

O992, E050

ICD-10 Finland

+∞

6.2

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.2

1589

14069

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

6.2

1499

13215

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

7.0

6.2

A02BA02

ATC

ranitidine; systemic

1.2

6.2

1092

9382

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.2

1616

14342

R01AD12

ATC

fluticasone furoate; nasal

1.1

6.2

1964

17677

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.6

6.1

138

858

C08DB01

ATC

diltiazem; oral

1.5

6.1

203

1381

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

2.3

6.1

232

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

6.1

201

1365

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

6.1

155

990

I50

ICD-10 Finland

Heart failure

1.7

6.1

110

642

SPAT1342

SPAT

Referral to specialised care

2.1

6.1

322

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

3.3

6.0

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

3.3

6.0

R05

ICPC

Cough

1.2

6.0

1332

11663

N01

ICPC

Headache

1.3

6.0

570

4592

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.1

6.0

281

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3015377) Calcium [Moles/volume] in Serum or Plasma

4283

25497

2.28

312.93

3.4

3.3

mmol/l

2.3

2.4

57.00

3839

22334

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5189

4699

24.28

307.65

7.5

2.4

pmol/l

4.7

4.4

33.10

4895

4134

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2061

5284

4.75

307.65

3.2

3.6

ng/l

51.3

87.4

82.42

1870

4515

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2246

6097

4.56

307.65

1.4

1.2

iu/ml

208.0

147.5

5.96

1051

2352

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1396

244

67.36

307.65

7.9

4.6

—

(3018418) pH of Serum or Plasma

4299

21654

2.86

307.65

6.1

3.8

7.4

0.43

770

4180

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8865

72698

8.64

307.65

15.8

4.7

mu/l

1.9

2.0

0.12

8572

67358

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5699

32770

2.97

307.65

7.6

5.5

mmol/l

1.2

33.72

5324

29653

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

941

1903

5.40

307.65

1.4

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1497

545

32.66

307.65

7.7

2.7

u/ml

67.2

128.9

1.20

553

145

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6159

36335

3.14

307.65

9.0

6.1

mmol/l

1.2

40.69

5245

30573

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8804

62668

12.44

307.65

14.0

4.0

pmol/l

16.1

14.6

307.65

8528

57613

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

3549

1524

37.47

307.65

2.9

1.3

iu/l

23.1

10.5

0.47

2067

414

(3013650) Neutrophils [#/volume] in Blood by Automated count

5968

44407

1.99

203.25

9.3

9.1

e9/l

3.8

4.0

7.20

5169

38845

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4791

33331

1.92

196.61

2.6

2.3

nmol/l

76.2

2782.7

0.50

4422

30313

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7207

58506

2.10

177.39

8.9

7.3

u/l

77.7

76.7

1.39

6890

55075

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

222

263

8.63

172.88

1.7

1.5

pmol/l

17.7

14.3

3.32

196

220

(3044640) Blood type and Crossmatch panel - Blood

3566

24145

1.78

144.89

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

482

1448

3.46

131.50

2.2

2.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1925

11505

1.85

113.26

3.6

3.2

mmol/l

0.8

5.15

1801

10738

(3013707) Erythrocyte sedimentation rate by Westergren method

6848

57828

1.74

108.41

4.2

4.1

mm/h

11.5

11.8

0.69

6399

53838

(3019550) Sodium [Moles/volume] in Serum or Plasma

8595

78410

2.65

107.66

17.4

14.2

mmol/l

139.8

139.7

4.28

8442

76443

(3023103) Potassium [Moles/volume] in Serum or Plasma

8605

78637

2.65

105.67

17.7

14.3

mmol/l

3.9

11.19

8432

76505

(40758558) Short blood count panel - Blood

2850

19415

1.68

104.75

7.1

6.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2694

18222

1.68

100.97

2.1

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

995

4933

2.14

99.20

2.4

1.7

—

(3044889) 12 lead EKG panel

6273

52315

1.64

97.86

4.2

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4647

36319

1.57

93.58

3.8

3.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

4720

37182

1.56

90.57

5.7

6.1

28.6

28.7

0.19

4368

34658

(3019069) Monocytes/100 leukocytes in Blood

4598

36101

1.55

88.87

5.9

6.3

8.5

8.4

1.59

4277

33800

(3022096) Basophils/100 leukocytes in Blood

4458

34768

1.55

88.78

5.7

6.1

0.7

1.70

4118

32382

(3006504) Eosinophils/100 leukocytes in Blood

4575

35914

1.55

88.26

5.7

6.0

2.8

0.15

4241

33415

(3018010) Neutrophils/100 leukocytes in Blood

4640

36682

1.54

85.64

5.5

5.9

56.8

56.9

0.23

4312

34301

(3013826) Glucose [Moles/volume] in Serum or Plasma

5264

42807

1.54

85.10

4.9

4.3

mmol/l

6.6

0.05

4939

39690

(3013115) Eosinophils [#/volume] in Blood

4953

39871

1.53

82.95

5.8

6.1

e9/l

0.2

0.08

4370

35144

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1465

8780

1.80

82.57

4.8

5.5

mmol/l

1.1

1.0

3.41

1356

8162

(42870588) Differential panel, method unspecified - Blood

3436

25663

1.54

80.76

5.4

5.9

—

(3019198) Lymphocytes [#/volume] in Blood

4897

39571

1.51

78.72

5.6

5.9

e9/l

1.9

1.47

4321

34961

(3006315) Basophils [#/volume] in Blood

4776

38532

1.50

76.37

5.6

5.9

e9/l

0.0

3.86

4118

33377

(3001604) Monocytes [#/volume] in Blood

4758

38377

1.50

76.03

5.6

5.8

e9/l

0.6

0.31

4108

33266

(3024561) Albumin [Mass/volume] in Serum or Plasma

4061

31769

1.50

74.93

4.5

4.6

g/l

36.1

35.9

1.86

3774

29523

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2007

13523

1.62

72.14

3.0

2.9

mmol/l

2.4

2.5

13.11

1736

11840

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7961

72475

1.77

70.37

14.8

11.8

ml/min/173m2

84.4

83.5

3.43

6827

59649

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8368

77441

1.97

69.02

15.3

12.9

mg/l

20.3

21.6

3.22

6788

60726

(40768804) Tissue Pathology biopsy report

4145

33073

1.46

66.31

2.2

2.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8713

82171

2.33

63.20

13.0

10.0

u/l

24.7

25.3

2.85

8535

79444

(40761511) CBC panel - Blood by Automated count

8613

81003

2.12

60.50

16.4

12.1

—

(3033658) Prothrombin time (PT) actual/Normal

2560

18866

1.50

59.65

4.0

3.7

92.8

94.0

1.75

2506

18345

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1190

7328

1.72

59.40

2.3

2.2

nmol/l

373.0

375.5

0.15

1097

6715

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2511

18524

1.49

57.86

1.3

u/ml

1.9

1.5

0.76

623

5111

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

12.20

57.28

7.5

1.8

pmol/l

120.7

23.5

1.23

(3021589) Normoblasts [#/volume] in Blood

4158

33890

1.42

55.57

10.5

9.1

e9/l

0.0

0.22

3401

27638

(3002385) Erythrocyte distribution width [Ratio]

7208

64973

1.52

55.28

21.3

15.6

13.6

0.83

7108

63639

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4661

38856

1.41

54.17

6.3

5.9

umol/l

10.9

10.5

1.03

4432

36722

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1003

6069

1.73

52.97

5.1

3.5

mmol/l

1.2

22.32

900

5295

(3007164) IgA [Mass/volume] in Serum or Plasma

2152

15837

1.47

48.67

1.5

1.4

g/l

2.2

2.3

2.69

1249

9709

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4299

35766

1.38

48.26

3.2

2.9

ug/l

100.5

104.6

0.65

3998

33409

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7544

69456

1.50

44.50

5.8

5.3

mmol/mol

39.4

39.0

3.19

7021

64634

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7965

74281

1.57

43.25

4.7

4.3

mmol/l

5.9

5.8

2.54

7358

68367

(3032080) INR in Blood by Coagulation assay

3413

27755

1.37

42.23

10.2

7.6

inr

1.2

3.59

1023

8180

(3019225) pH of Specimen

1109

7287

1.59

41.94

6.1

4.0

—

(3035941) MCH [Entitic mass]

8930

86276

2.62

41.43

26.2

19.1

30.0

30.2

21.32

8869

85190

(3024731) MCV [Entitic volume]

8930

86281

2.62

41.33

26.3

19.1

90.4

90.8

20.37

8870

85199

(3007461) Platelets [#/volume] in Blood

8926

86228

2.60

41.26

26.4

19.2

e9/l

260.3

259.6

0.49

8802

84205

(3026361) Erythrocytes [#/volume] in Blood

8930

86290

2.62

41.15

26.4

19.1

e12/l

4.5

36.69

8782

84069

(3000963) Hemoglobin [Mass/volume] in Blood

8931

86314

2.62

40.96

26.5

19.2

g/l

135.1

134.1

12.31

8869

85239

(3010813) Leukocytes [#/volume] in Blood

8929

86307

2.59

40.55

26.4

19.2

e9/l

6.6

2.26

8780

84056

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3628

29935

1.35

40.29

2.0

1.9

pmol/l

95.6

98.0

2.00

1883

15182

(4035726)

1039

6793

1.60

40.02

1.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1807

13432

1.43

37.26

4.0

3.5

ng/l

142.4

437.2

3.10

1323

9586

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2378

18577

1.38

36.58

3.9

2.8

ng/l

1181.3

1147.3

0.18

2031

15806

(3010838) Calcium [Moles/time] in 24 hour Urine

130

399

3.29

34.28

1.7

mmol/24h

5.1

6.3

0.47

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2342

18482

1.36

33.19

2.3

2.2

mg/l

2.8

2.9

0.68

2023

15851

(36660697) Celiac disease serology panel - Serum

977

6603

1.54

32.15

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

7635

71496

1.42

31.63

19.5

13.8

40.0

39.5

6.92

5782

53428

(3002256) Pathology report gross observation

1394

10248

1.43

29.84

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1276

9497

1.40

25.08

2.6

2.5

22.9

22.7

0.17

1088

8129

(3022948) Iron [Moles/volume] in Serum or Plasma

1471

11219

1.37

24.92

2.5

2.4

umol/l

13.5

13.3

0.42

1356

10410

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1360

10272

1.38

24.43

2.5

2.4

g/l

2.4

1.02

1251

9511

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5741

52289

1.26

24.32

3.1

3.0

u/l

42.3

43.2

0.37

5392

49014

(3003694) ABO and Rh group [Type] in Blood

2616

21732

1.29

24.14

1.5

—

(3013512) EKG study

2504

20711

1.29

23.86

3.9

3.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

128

4.47

23.51

1.1

pmol/l

2.7

5.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2145

17457

1.30

22.99

2.6

1.7

mg/l

1.0

1.1

0.53

1632

13224

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

783

5409

1.49

22.91

4.1

2.7

ng/l

225.2

166.4

2.05

706

4904

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

543

3464

1.60

22.80

9.8

9.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

226

1111

2.06

22.62

3.4

3.1

nmol/l

0.8

0.39

181

853

(3031040) Bacteria [#/volume] in Urine by Automated count

5600

51124

1.25

21.97

4.7

4.4

e6/l

1815.7

1940.4

0.05

631

(3000991) Gas panel - Venous blood

772

5362

1.48

21.96

8.8

7.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2794

23637

1.26

21.69

2.6

2.5

u/l

56.3

57.4

0.52

2559

21786

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3115

26687

1.25

21.68

3.7

3.3

ng/l

40.1

61.5

0.54

1910

16462

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1148

8615

1.38

21.23

2.6

umol/l

7.7

7.5

0.08

1003

7360

(3037467) Urinalysis macro (dipstick) panel - Urine

5797

53242

1.24

21.00

4.5

4.3

—

(3016502) Oxygen saturation in Arterial blood

900

6522

1.42

20.39

7.6

7.3

95.4

95.9

1.28

860

6271

(3002032) Base excess in Venous blood by calculation

814

5793

1.44

20.37

3.4

3.7

mmol/l

2.0

0.07

674

4740

(3027801) Oxygen [Partial pressure] in Arterial blood

1001

7398

1.40

20.24

7.4

6.9

kpa

12.3

12.7

1.32

950

7059

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1001

7400

1.40

20.21

7.4

6.9

kpa

5.1

0.95

951

7065

(3021447) Carbon dioxide [Partial pressure] in Venous blood

815

5811

1.44

20.18

3.4

3.7

kpa

5.9

5.8

1.36

775

5642

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2402

20096

1.27

20.18

1.7

1.6

mmol/l

1.3

1.4

0.77

2031

17022

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8072

77372

1.37

20.14

4.9

4.6

mmol/l

2.8

2.9

3.26

7494

71744

(3003396) Base excess in Arterial blood by calculation

995

7374

1.39

19.77

7.4

6.9

mmol/l

1.0

1.1

0.13

791

5792

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

982

7262

1.39

19.77

3.2

—

(36304419) Bacteria [Presence] in Urine

2336

19570

1.26

19.22

3.2

2.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1420

11165

1.32

19.17

2.9

2.7

e6/l

4.2

3.6

0.84

737

5824

(3052851) Hemolysis interference index of Serum or Plasma

361

2178

1.68

18.92

3.2

3.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2557

21703

1.25

18.66

2.1

u/l

188.3

193.3

0.06

2400

20357

(3030467) Casts [#/volume] in Urine by Automated count

2355

19876

1.25

17.93

3.2

3.0

e6/l

0.4

0.19

1753

14739

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

502

3324

1.54

17.91

10.1

8.8

mmol/l

24.6

24.3

1.29

469

3120

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7934

76141

1.32

17.24

4.5

4.2

mmol/l

4.7

4.8

14.57

7399

70991

(3002173) Hemoglobin [Mass/volume] in Arterial blood

826

6094

1.39

16.77

8.1

7.7

g/l

122.4

120.9

1.32

795

5858

(3014111) Lactate [Moles/volume] in Serum or Plasma

778

5683

1.40

16.75

7.8

6.6

mmol/l

1.2

1.3

1.45

741

5497

(3002582) Erythrocytes [#/volume] in Urine

2525

21617

1.23

16.61

3.3

3.0

e6/l

50.4

71.7

0.68

1904

16321

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2911

25316

1.22

16.39

3.4

3.2

u/l

29.6

33.6

2.74

2777

24030

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1368

10948

1.29

15.96

1.9

1.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

205

1108

1.87

15.72

1.6

1.3

nmol/l

0.3

0.01

(3037522) Nuclear Ab [Titer] in Serum

1428

11519

1.28

15.64

1.4

titre

446.5

560.0

2.25

321

2495

(3022217) INR in Platelet poor plasma by Coagulation assay

1082

8410

1.33

15.63

26.4

21.3

inr

1.5

1.3

3.13

144

1247

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

191

1011

1.91

15.62

1.6

1.2

—

(3026782) Osmolality of Urine

1688

13905

1.26

15.55

2.6

2.7

mosm/kgh2o

523.1

528.5

0.46

1422

11770

(3018095) Leukocytes [#/volume] in Urine

2980

26081

1.21

15.52

3.8

3.5

e6/l

77.0

102.0

1.42

2059

17823

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

453

3028

1.52

15.49

3.8

4.1

mmol/l

24.5

24.3

0.56

425

2724

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

976

7490

1.34

15.38

5.9

4.1

u/l

233.3

242.3

1.54

921

7055

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7871

75665

1.29

15.31

4.4

4.1

mmol/l

1.5

19.97

7304

70267

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

567

3982

1.45

15.17

8.3

6.6

mmol/l

24.9

0.16

562

3954

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

223

1257

1.79

14.95

1.2

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1482

12108

1.27

14.54

2.8

2.6

e6/l

1.0

1.5

1.07

791

6734

(3035637) Corticotropin [Mass/volume] in Plasma

177

955

1.87

13.70

1.7

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

161

843

1.93

13.66

1.1

1.2

u/l

77.3

58.0

1.89

111

572

(3036603) Volume of Urine

105

469

2.25

13.59

1.7

1.5

1923.0

1979.2

0.12

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

915

7080

1.32

13.56

2.5

2.4

u/l

41.5

43.6

0.09

792

6033

(3023368) Bacteria identified in Blood by Culture

2109

18053

1.22

13.37

4.2

4.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

945

7367

1.32

13.28

1.8

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

929

7227

1.32

13.25

2.4

2.5

1.7

1.8

0.63

830

6409

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7593

72945

1.24

13.08

3.9

3.7

mmol/l

1.3

0.07

6999

67314

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1695

14219

1.24

13.02

1.3

u/ml

8.8

11.8

1.14

611

5774

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

943

7376

1.31

12.92

1.8

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1036

8236

1.29

12.55

7.6

6.6

mmol/l

104.4

0.02

1016

8066

(3019309) Folate [Moles/volume] in Red Blood Cells

1549

12919

1.24

12.51

1.7

nmol/l

1085.2

1185.3

4.83

1217

9842

(3021960) Folate [Moles/volume] in Serum or Plasma

1921

16438

1.21

12.04

1.5

nmol/l

20.4

21.0

0.59

1653

14081

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

369

2500

1.50

11.89

2.0

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

128

651

1.98

11.88

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1761

14968

1.22

11.78

1.3

iu/ml

30.9

33.4

0.28

526

4736

(3047181) Lactate [Moles/volume] in Blood

318

2093

1.54

11.75

4.6

5.9

mmol/l

1.3

0.12

280

1840

(3004119) Hemoglobin [Mass/volume] in Venous blood

526

3837

1.39

11.40

3.0

3.2

g/l

132.0

128.7

2.89

504

3737

(3026493) Urate [Moles/volume] in Serum or Plasma

2177

18955

1.20

11.22

2.4

umol/l

2962.0

3859.2

0.58

1881

16512

(40760892) CBC W Ordered Manual Differential panel - Blood

2042

17692

1.20

11.09

3.9

4.4

—

(3009508) Creatinine [Moles/volume] in Urine

2463

21740

1.18

10.77

3.3

3.1

mmol/l

7.2

0.09

2043

18339

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1866

16072

1.20

10.76

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

269

1743

1.56

10.70

2.4

2.2

g/l

0.0

0.00

250

1614

(3000492) Spirometry study

933

7466

1.28

10.68

1.5

1.4

—

(40768797) Stomach Pathology biopsy report

1300

10833

1.23

10.44

1.2

—

(3012516) Albumin [Mass/volume] in Urine

2267

19914

1.18

10.43

3.5

3.2

mg/l

647.0

416.2

1.03

1393

11951

(3020630) Protein [Mass/volume] in Serum or Plasma

706

5465

1.32

10.40

2.7

2.5

g/l

65.7

66.7

3.31

649

4978

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

271

1771

1.55

10.39

2.5

2.2

g/l

0.0

0.78

250

1620

(3000850) Epithelial cells [#/volume] in Urine

1754

15077

1.20

10.29

2.6

2.5

e6/l

6.3

6.8

0.69

1503

13116

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

346

2387

1.47

10.23

2.4

2.3

g/l

3.1

0.11

269

1854

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1979

1.51

10.22

2.4

2.1

g/l

37.8

38.0

0.19

258

1702

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

287

1909

1.52

10.15

2.4

2.2

g/l

0.0

1.12

266

1751

(3017732) Neutrophils [#/volume] in Blood

720

5614

1.31

10.06

2.8

2.7

e9/l

4.0

0.47

584

4470

(3020682) Albumin/Creatinine [Ratio] in Urine

2359

20857

1.18

9.97

4.2

3.9

mg/mmol

8.2

8.7

0.21

1402

12657

(3020779) Urea [Moles/volume] in Serum or Plasma

713

5561

1.31

9.94

10.2

7.2

mmol/l

9.2

9.0

0.22

681

5319

(3042936) Bacteria identified in Isolate by Culture

1210

10058

1.23

9.92

2.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

316

2161

1.48

9.79

2.7

2.3

g/l

0.4

0.9

2.49

277

1868

(3011985) Renin [Units/volume] in Plasma

174

1037

1.69

9.74

1.9

1.5

mu/l

48.3

53.9

0.30

146

927

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

193

2.65

9.57

1.4

1.6

ug/l

0.4

0.03

127

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

147

842

1.76

9.50

2.6

3.1

nmol/l

5.5

11.8

0.46

140

816

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2523

1.44

9.49

2.4

2.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5636

53254

1.15

9.48

3.3

3.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2527

1.43

9.41

2.5

2.2

g/l

7.4

0.17

275

1900

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

2521

1.43

9.36

2.5

2.2

g/l

3.7

3.8

0.55

264

1807

(3012565) Volume of 24 hour Urine

369

2.15

9.31

2.4

2.1

1911.5

1918.4

0.02

335

(3023323) Follitropin [Units/volume] in Serum or Plasma

660

5149

1.30

9.19

1.4

1.3

iu/l

30.4

0.00

570

4468

(3024928) Oxygen saturation in Venous blood

209

1329

1.59

9.08

3.1

3.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

340

2409

1.43

8.78

1.1

u/ml

6.6

6.1

0.06

308

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

292

2022

1.46

8.53

4.3

3.2

u/ml

0.4

0.00

168

1133

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

514

1.92

8.45

1.5

u/l

6.4

5.6

0.21

247

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

342

2447

1.41

8.38

1.6

1.8

g/l

0.2

0.58

316

2320

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2351

1.42

8.28

2.5

2.2

g/l

9.8

10.3

1.60

278

1972

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

7.07

7.99

1.4

2.2

—

(3022145) Colonoscopy Study observation

1027

8584

1.22

7.92

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

439

3304

1.35

7.90

2.1

2.0

u/l

38.5

39.6

0.57

386

2971

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

205

1347

1.53

7.78

1.4

1.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

522

4047

1.31

7.65

10.0

8.4

1.3

1.4

1.03

517

4019

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

346

2523

1.39

7.62

1.6

1.8

g/l

1.2

0.77

320

2400

(3020961) Endomysium IgA Ab [Titer] in Serum

516

3997

1.31

7.61

1.1

titre

116.9

201.6

0.89

(3048689) Calprotectin [Mass/mass] in Stool

1208

10314

1.20

7.45

2.0

2.3

ug/g

103.1

123.2

1.27

931

8041

(3005719) IgG [Mass/volume] in Serum or Plasma

713

5768

1.26

7.44

2.5

2.7

g/l

10.1

10.4

1.57

647

5288

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

404

1.96

7.39

1.1

u/l

67.7

79.7

1.43

316

(3019060) Gas panel - Arterial blood

539

4218

1.30

7.37

4.0

4.8

—

(3026008) Bacteria identified in Urine by Culture

2613

23710

1.14

7.37

3.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1028

8667

1.21

7.25

1.9

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

401

1.95

7.20

1.2

1.1

u/l

13.3

21.9

2.17

307

(3039000) Anion gap in Blood

218

1479

1.49

7.14

5.2

6.9

mmol/l

11.4

11.2

0.51

196

1318

(40761536) Microorganisms panel - Urine sediment

806

6642

1.23

7.13

3.8

—

(3018572) Chloride [Moles/volume] in Blood

218

1480

1.48

7.12

5.2

6.9

mmol/l

105.6

105.2

0.68

196

1319

(3004588) Protein electrophoresis panel - Serum or Plasma

568

4509

1.28

6.96

2.6

2.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

334

2462

1.37

6.92

1.3

u/ml

50.8

39.1

0.28

161

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

102

581

1.76

6.85

2.3

2.0

nmol/l

18.0

18.8

0.40

543

(3009445) Proteinase 3 Ab [Units/volume] in Serum

401

3053

1.33

6.72

1.5

1.6

u/ml

12.5

14.6

0.13

(3023520) Reticulocytes [#/volume] in Blood

659

5352

1.25

6.66

2.3

2.5

e9/l

73.1

70.6

0.76

477

3991

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1216

10505

1.18

6.53

2.9

2.1

30.3

29.5

4.17

1175

10175

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

263

1882

1.41

6.53

1.2

1.3

u/ml

34.0

45.2

0.64

204

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

475

1.82

6.43

1.1

1.2

u/l

20.1

19.9

0.01

406

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

287

2094

1.38

6.36

2.2

2.1

mg/l

10.5

11.1

0.61

268

1946

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

151

972

1.56

6.36

1.4

1.3

pmol/l

271.2

330.2

1.01

120

753

(3003338) MCHC [Mass/volume]

6890

66654

1.14

6.36

22.8

16.4

g/l

331.6

331.8

1.13

6858

66196

(3011648) Oxygen content in Venous blood

521

1.77

6.34

2.0

2.6

11.1

11.3

0.11

521

(3035320) C reactive protein [Mass/volume] in Body fluid

558

1.75

6.33

2.3

2.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

4078

38283

1.12

6.32

4.9

estimate

0.0

2.09

792

7227

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

327

2442

1.35

6.27

1.5

1.6

titre

103.1

339.5

3.51

119

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

137

2.56

6.26

1.5

1.4

ng/l

73.6

103.2

1.15

137

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

114

2.73

6.26

1.6

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

142

905

1.58

6.25

1.6

1.5

iu/ml

26.4

30.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

498

3944

1.28

6.24

1.7

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

447

3492

1.29

6.24

1.3

u/ml

0.4

1.2

3.00

331

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

380

2906

1.32

6.20

1.8

1.7

g/l

1.5

0.17

327

2481

(3017446) Testosterone [Moles/volume] in Serum or Plasma

402

3099

1.31

6.20

2.2

2.1

nmol/l

11.0

11.6

0.64

356

2719

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

102

599

1.71

6.20

1.1

1.2

titre

182.5

188.5

0.02

123

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

298

2.02

6.16

1.7

2.1

ug/l

63.0

60.8

0.09

288

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

489

1.79

6.16

1.1

1.2

u/l

74.0

81.8

0.28

433

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

639

5230

1.24

6.04

1.6

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

480

3805

1.28

5.99

2.8

3.3

mmol/l

2.0

1.8

0.64

350

2832

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

814

6840

1.21

5.95

2.2

g/l

0.2

0.20

767

6392

(3021387) Prolactin [Units/volume] in Serum or Plasma

394

3048

1.31

5.94

1.5

1.6

mu/l

310.2

304.8

0.12

344

2736

(3009261) Glucose [Presence] in Urine by Test strip

4104

38627

1.11

5.93

3.6

3.7

estimate

0.0

0.16

778

7131

(3027273) Bicarbonate [Moles/volume] in Venous blood

388

2997

1.31

5.91

2.9

3.2

mmol/l

26.1

25.3

4.43

361

2904

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

202

1406

1.45

5.88

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

202

1406

1.45

5.88

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

183

1252

1.47

5.83

1.9

1.6

g/l

0.8

0.7

0.74

133

933

(3003434) Protein [Mass/volume] in Pleural fluid

116

722

1.61

5.68

1.5

g/l

32.1

32.8

0.26

109

653

(3008152) Bicarbonate [Moles/volume] in Arterial blood

505

4056

1.26

5.66

5.7

6.9

mmol/l

24.9

24.6

1.09

464

3768

(3007566) Smooth muscle Ab [Titer] in Serum

293

2188

1.35

5.66

1.3

1.2

titre

112.4

137.4

0.34

207

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

499

4005

1.26

5.63

2.9

3.3

kpa

5.2

0.85

459

3710

(3005322) IgE [Units/volume] in Serum or Plasma

643

5309

1.23

5.62

1.3

u/ml

150.7

186.4

0.94

597

4895

(3009343) pH of Capillary blood

493

3956

1.26

5.58

2.8

3.3

7.4

0.12

532

(3035350) Ketones [Presence] in Urine by Test strip

4041

38088

1.11

5.55

3.6

estimate

0.0

1.08

781

7094

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

630

5219

1.22

5.34

1.2

1.3

au/ml

51.8

47.0

0.14

222

(3028026) IgM [Mass/volume] in Serum or Plasma

550

4493

1.24

5.32

1.9

g/l

1.3

0.13

506

4119

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

380

1.82

5.28

1.7

nmol/l

4.6

4.2

0.05

306

(3051611) Lipemic interference index of Serum or Plasma

117

744

1.58

5.27

4.7

3.0

—

(3035880) pH of Pleural fluid

295

1.94

5.27

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

681

5698

1.21

5.22

2.3

2.4

au/ml

21.0

25.1

0.51

351

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

184

1290

1.44

5.20

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

474

1.72

5.06

1.0

1.1

nmol/l

16.2

7.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

279

2113

1.33

4.95

2.3

2.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

877

7565

1.18

4.79

3.4

3.9

ug/l

11.4

26.4

1.73

670

5948

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

9.01

4.78

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

103

652

1.59

4.77

1.5

1.4

e6/l

1736.8

2348.7

0.92

477

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

254

1911

1.34

4.74

1.5

iu/ml

3.7

14.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

292

2245

1.31

4.68

1.4

ug/g

290.3

284.1

0.20

175

1245

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

969

8442

1.17

4.68

1.5

1.4

—

(3010421) pH of Blood

242

1814

1.34

4.63

3.4

3.7

7.4

0.14

201

1522

(3034770) Mitochondria Ab [Titer] in Serum

287

2205

1.31

4.63

1.3

1.2

titre

531.4

997.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

361

1.78

4.58

1.4

1.3

u/l

12.0

11.9

0.05

328

(3009214) Lutropin [Units/volume] in Serum or Plasma

278

2130

1.31

4.58

1.4

1.3

u/l

12.5

12.3

0.05

223

1737

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

320

2510

1.28

4.44

3.1

3.5

mmol/l

24.9

25.0

0.04

293

2320

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1236

11006

1.14

4.41

4.9

4.7

ug/l

2.1

2.6

2.20

1084

9865

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

285

2204

1.30

4.40

3.1

2.2

ug/l

420.2

557.1

0.48

263

2040

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

450

3681

1.23

4.36

2.1

u/l

6431.8

5168.5

0.32

155

1453

(3006184) Hemoglobin [Mass/volume] in Capillary blood

208

1539

1.36

4.36

1.9

2.1

g/l

131.9

128.7

0.91

131

1100

(3036489) Thrombin time

357

2847

1.26

4.34

2.7

2.0

22.2

21.2

0.76

310

2431

(3049717) Cytology report of Urine Cyto stain

270

2080

1.31

4.30

2.6

2.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

635

5387

1.19

4.24

2.3

ug/l

10.1

6.6

1.55

536

4682

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1722

15691

1.12

4.23

1.6

pmol/l

42747454.2

33841208.8

0.25

1427

13138

(3021788) Differential panel - Synovial fluid

180

1313

1.38

4.14

1.6

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

473

0.40

4.14

17.8

17.4

nmol/l

1512.9

3458.7

0.48

460

(3028308) Erythrocytes [#/volume] in Pleural fluid

582

1.57

4.10

1.5

1.4

e6/l

23505.4

60973.2

1.63

342

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

288

2255

1.29

4.08

1.3

u/ml

17.5

7.2

0.49

367

(3048929) Epstein Barr virus Ab [Presence] in Serum

305

2407

1.28

4.06

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

128

883

1.46

4.04

1.5

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

568

4795

1.20

4.02

3.2

3.1

kpa

4.6

0.17

545

4640

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

214

1613

1.33

4.01

1.5

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

284

2227

1.28

3.99

1.3

u/ml

2.4

5.2

0.99

227

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

159

1145

1.40

3.97

1.6

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

333

2666

1.26

3.95

4.3

5.0

1.7

0.57

310

2485

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

168

1223

1.38

3.94

1.1

u/ml

3.0

3.3

0.16

594

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

285

3599

0.79

3.92

1.4

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

460

0.41

3.89

14.4

12.2

nmol/l

752.9

826.6

0.30

441

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

171

2.05

3.89

1.2

1.1

pmol/l

460.9

299.9

0.61

127

(3012501) Base excess in Blood by calculation

205

1549

1.33

3.79

3.6

3.8

mmol/l

2.6

2.5

0.01

138

1052

(3051651) Icteric interference index of Serum or Plasma

430

1.63

3.75

5.4

3.3

—

(3022313) Gas panel - Capillary blood

352

2856

1.24

3.73

3.0

3.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

259

1.82

3.70

34.5

3.8

mg/l

65.3

853.7

0.50

185

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

206

1566

1.32

3.67

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

298

2378

1.26

3.66

3.1

2.1

93.1

93.8

0.23

277

2201

(4010399)

633

5453

1.17

3.57

1.5

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

100

676

1.48

3.55

1.2

1.3

titre

—

(1616796) Gas panel - Central venous blood

195

1480

1.32

3.53

3.1

3.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

275

2184

1.27

3.53

3.4

2.5

g/l

3.5

3.6

0.77

258

2063

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

328

2661

1.24

3.50

1.8

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

253

1992

1.28

3.49

3.7

3.3

mg/l

36.0

80.6

0.90

213

1596

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

121

852

1.43

3.48

1.6

1.8

pmol/l

171.6

183.9

0.58

109

799

(3041096) Erythrocytes [Presence] in Urine by Automated

2249

20972

1.10

3.46

3.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

278

2217

1.26

3.45

3.6

2.4

181.7

185.0

0.27

259

2101

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

359

2947

1.23

3.44

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

730

1.46

3.44

1.5

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

253

1998

1.27

3.41

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

585

1.51

3.40

1.5

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

687

5983

1.16

3.39

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

252

1993

1.27

3.37

3.7

3.3

mg/l

26.6

49.0

2.43

210

1600

(40767503) Oxygen content in Capillary blood by calculation

187

1425

1.32

3.32

2.3

2.4

16.8

16.3

0.61

705

(1002224) Polysomnography panel

392

3260

1.21

3.31

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

162

1.98

3.28

1.3

mu/l

114.9

77.7

0.35

127

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

447

1.57

3.25

1.2

—

(4094501)

242

1915

1.27

3.23

1.1

—

(40768806) Pleura Pathology biopsy report

584

1.49

3.23

1.8

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

514

4393

1.18

3.22

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.38

3.22

1.2

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

646

5626

1.16

3.20

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.27

3.18

1.3

—

88.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

323

2649

1.23

3.15

4.4

5.1

0.9

0.51

299

2475

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

252

2013

1.26

3.12

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

152

1137

1.34

3.09

1.1

iu/ml

174.9

9923.5

0.64

275

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

307

2512

1.23

3.07

3.2

3.4

u/ml

1611.5

1349.1

0.07

257

2127

(3045788) Cell count panel - Pleural fluid

518

1.51

3.06

1.6

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

215

1690

1.28

3.05

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

114

816

1.40

3.04

1.1

—

(3025159) Blasts/100 leukocytes in Blood

653

5716

1.15

3.03

3.6

4.2

0.1

0.4

1.52

156

1310

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

299

2445

1.23

3.02

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

5.84

3.02

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

242

1934

1.26

3.00

3.7

3.2

ratio

1.4

1.7

0.37

173

(3012441) Differential panel - Pleural fluid

548

1.48

2.93

1.6

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1406

12918

1.10

2.93

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

101

2.18

2.92

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

169

1296

1.31

2.91

1.6

1.7

nmol/l

43.3

43.7

0.07

161

1254

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

503

1.50

2.84

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

716

6339

1.14

2.84

2.8

2.9

ug/l

0.7

0.8

0.48

479

4116

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

643

1.44

2.83

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

326

2711

1.21

2.81

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

646

1.43

2.77

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

129

960

1.35

2.75

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

178

1388

1.29

2.73

1.4

u/ml

142.0

113.7

0.45

298

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

648

1.42

2.73

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

5.00

2.72

1.0

1.4

1.5

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

473

4077

1.17

2.72

1.6

1.5

—

(3020491) Glucose [Moles/volume] in Blood

558

1.46

2.70

1.8

2.0

mmol/l

6.8

6.5

0.47

398

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

103

742

1.39

2.69

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

123

913

1.35

2.68

1.9

2.1

mg/l

34.3

26.8

0.50

237

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

643

1.42

2.66

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

257

1.68

2.66

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

966

8754

1.12

2.62

4.1

4.0

23.0

21.6

2.13

431

4079

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

200

1592

1.26

2.62

2.7

3.7

57.7

57.4

0.11

200

1592

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

269

2213

1.22

2.61

1.2

—

(3042733) HLA Ab [Presence] in Serum

206

1.75

2.60

6.2

5.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

646

1.41

2.60

1.2

—

(3006270) Folate [Moles/volume] in Blood

621

1.42

2.60

1.1

nmol/l

398.2

379.3

0.39

548

(3034274) Bile acid [Moles/volume] in Serum --fasting

150

1152

1.31

2.60

1.7

2.1

umol/l

6.3

6.9

0.22

101

841

(3028626) Oxygen [Partial pressure] in Capillary blood

174

1364

1.28

2.58

2.3

2.7

kpa

8.3

0.02

158

1262

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

275

1.64

2.57

2.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

107

2.06

2.56

1.1

1.2

mmol/l

1.6

1.7

0.31

(3017143) Hepatitis C virus Ab [Presence] in Serum

1015

9237

1.11

2.56

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

375

3191

1.18

2.55

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

138

1052

1.32

2.53

1.6

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

191

1520

1.26

2.52

1.4

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

642

1.41

2.51

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

150

1159

1.30

2.50

1.3

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

164

1284

1.28

2.48

1.2

u/ml

3.7

3.3

0.12

419

(3023511) Choriogonadotropin [Units/volume] in Urine

236

1929

1.23

2.46

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

2.42

0.0

1.3

—

577.5

—

(3017181) Myelocytes/100 leukocytes in Blood

706

6316

1.13

2.41

3.6

4.1

1.0

0.9

0.43

186

1664

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

288

1.60

2.41

1.1

1.2

g/l

0.3

0.26

230

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

130

991

1.32

2.40

1.2

u/l

25.5

33.5

0.57

112

861

(3021440) Promyelocytes/100 leukocytes in Blood

676

6037

1.13

2.38

3.7

4.2

0.1

0.2

0.57

171

1544

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

343

2918

1.18

2.36

3.2

2.8

0.6

0.7

1.85

337

2797

(3014271) Vancomycin [Susceptibility]

299

1.57

2.32

2.7

3.0

—

(3004451) EKG impression Narrative

315

1.56

2.31

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

428

1.48

2.31

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.18

2.30

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

586

1.40

2.30

1.2

1.3

u/ml

0.2

1.3

1.90

260

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

110

827

1.33

2.26

9.6

6.3

mg/l

12.5

11.6

1.31

101

767

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

158

1248

1.27

2.26

1.3

1.2

u/ml

5.6

3.9

0.81

526

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1001

9168

1.10

2.25

4.6

4.2

32.5

32.7

0.38

711

6289

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

614

1.39

2.25

4.3

4.0

—

(4062490)

108

811

1.34

2.24

1.8

1.4

—

(3042631) Mycobacterium sp identified in Specimen

117

889

1.32

2.24

2.1

2.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

116

881

1.32

2.23

1.4

1.6

53.2

56.0

0.33

536

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

440

1.46

2.22

2.2

2.1

95.3

100.4

0.48

403

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

188

1519

1.24

2.22

1.4

1.3

u/ml

14.7

18.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

283

2383

1.19

2.21

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

133

1031

1.29

2.21

1.3

—

(3023410) Appearance of Cerebral spinal fluid

103

771

1.34

2.19

1.8

1.5

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

475

1.43

2.18

13.6

12.1

mmol/l

0.7

0.6

2.77

431

(3028433) Virus identified in Specimen by Culture

249

1.61

2.17

1.1

1.2

—

(40761535) Cells panel - Urine sediment

526

5931

0.88

2.17

3.8

3.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

142

1116

1.28

2.13

1.2

1.3

u/ml

48.0

55.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.21

2.10

1.9

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

236

1965

1.21

2.10

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

316

1.52

2.07

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

167

1344

1.25

2.07

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

506

1.41

2.06

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

184

1498

1.23

2.05

3.8

3.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

107

816

1.31

2.03

1.8

1.4

g/l

2.8

2.9

0.31

562

(3024139) IgG subclass 3 [Mass/volume] in Serum

107

817

1.31

2.01

1.8

1.4

g/l

0.3

0.4

2.14

560

(3027135) IgG subclass 1 [Mass/volume] in Serum

107

817

1.31

2.01

1.8

1.4

g/l

5.9

6.7

1.97

563

(3015235) Bicarbonate [Moles/volume] in Capillary blood

192

1574

1.22

2.01

2.4

2.9

mmol/l

25.2

24.9

0.38

171

1378

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.50

2.01

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

153

1225

1.25

1.99

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

138

1095

1.26

1.95

1.8

mmol/l

1.6

0.55

133

1071

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

149

1.75

1.94

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

164

1330

1.24

1.92

2.6

2.9

umol/l

31.0

34.5

1.27

137

1140

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

396

1.44

1.92

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

444

3923

1.14

1.91

2.5

2.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

128

1.80

1.89

1.3

ug/l

40.9

359.6

1.07

(3037756) Immunofixation for Serum or Plasma

158

1279

1.24

1.88

2.0

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

187

1541

1.22

1.88

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

111

861

1.29

1.88

1.2

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1894

17949

1.07

1.87

3.6

3.7

—

(3008295) Osmolality of Serum or Plasma

742

1.31

1.83

1.4

mosm/kgh2o

281.0

278.2

0.49

565

(3016650) Hepatitis A virus Ab [Presence] in Serum

152

1230

1.24

1.83

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1025

9498

1.09

1.82

1.7

1.8

—

(4034850)

212

2522

0.84

1.82

9.9

9.0

—

(3000494) Fungus identified in Specimen by Culture

971

8980

1.09

1.81

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

1196

1.24

1.81

1.3

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

614

1.34

1.80

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.96

1.79

1.1

1.3

mmol/l

1.6

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.76

1.79

1.3

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

439

0.61

1.79

1.0

ng/l

754.2

733.4

0.08

298

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

754

1.30

1.78

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

175

1442

1.22

1.78

5.8

5.4

iu/ml

366.3

831.9

0.91

182

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

296

1.49

1.76

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

216

1821

1.19

1.74

1.2

1.3

u/ml

1.0

3.7

1.54

130

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

140

1.72

1.71

1.5

2.5

mmol/l

6.4

7.2

1.09

(3017704) Immunofixation for Urine

340

1.44

1.69

2.1

1.5

—

(3044941) Cell count panel - Synovial fluid

139

1126

1.24

1.68

1.7

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

259

1.51

1.67

1.3

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

185

1547

1.20

1.65

1.5

1.4

nmol/l

0.4

0.16

140

1192

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.98

1.64

1.1

1.3

u/l

38.2

484.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

935

1.25

1.61

1.3

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

696

1.30

1.61

1.7

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

126

1016

1.24

1.61

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

101

794

1.28

1.59

1.1

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

472

1.36

1.58

1.4

1.5

u/l

4.9

5.9

1.43

400

(3008898) HLA-B27 [Presence]

351

3100

1.14

1.57

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

164

1364

1.21

1.56

1.2

titre

48.0

153.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

586

1.32

1.56

1.4

1.3

nmol/l

1.2

1.5

1.97

530

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

330

1.43

1.55

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

526

1.33

1.54

1.0

u/ml

0.4

1.7

1.06

153

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

174

1459

1.20

1.53

1.3

1.2

u/ml

279.1

279.5

0.01

118

925

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

147

1215

1.21

1.50

1.1

112.5

119.0

1.46

130

1099

(3000475) Leukocytes [#/volume] in Synovial fluid

203

1729

1.18

1.50

1.7

1.6

e6/l

13833.2

11386.6

0.39

147

1244

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

316

1.43

1.49

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

740

1.27

1.49

4.4

3.8

—

(44790049)

767

1.27

1.48

1.5

—

(44790047)

767

1.27

1.48

1.5

—

(44806118)

767

1.27

1.48

1.5

—

(44790048)

767

1.27

1.48

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

202

1.54

1.47

1.2

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

631

5787

1.10

1.46

3.5

3.9

0.8

0.6

1.32

133

1222

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

352

1.39

1.44

1.2

1.6

—

(3025941) Bacteria identified in Stool by Culture

511

4641

1.11

1.44

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

117

1.71

1.44

2.5

1.8

pmol/l

35.3

52.4

0.52

101

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.97

1.43

1.5

1.6

mg/l

0.3

1.6

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.97

1.43

1.5

1.6

mg/l

1.5

3.3

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.97

1.43

1.5

1.6

mg/l

0.9

2.2

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.97

1.43

1.5

1.6

mg/l

0.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

135

1114

1.22

1.42

2.3

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

319

2825

1.13

1.40

1.6

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

213

1.50

1.40

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

304

1.42

1.39

2.0

2.4

—

(3029075) Extractable nuclear Ab panel - Serum

230

1.48

1.38

1.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

347

1.39

1.38

1.3

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

140

1164

1.21

1.37

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

131

1577

0.83

1.36

3.4

mg/l

24.5

25.2

0.08

975

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

690

1.26

1.33

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

133

1105

1.21

1.33

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.78

1.32

1.1

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

123

1015

1.21

1.32

1.1

g/l

1.5

0.29

113

912

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

351

1.37

1.30

1.1

iu/ml

122.8

160.0

1.14

346

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.78

1.28

1.4

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

145

1.59

1.28

4.3

4.2

u/l

28.5

44.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.89

1.28

1.5

1.6

mg/l

0.7

2.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

114

1.67

1.28

1.1

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

775

1.24

1.27

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

722

1.25

1.26

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

196

1693

1.16

1.26

1.5

1.3

e6/l

57.6

30.2

0.42

140

1302

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

196

1694

1.16

1.25

1.6

1.4

e6/l

964.9

3688.7

0.66

150

1376

(3035285) Chloride [Moles/volume] in Venous blood

757

0.76

1.25

3.0

2.3

mmol/l

105.5

105.4

0.03

749

(3041354) Potassium [Moles/volume] in Venous blood

757

0.76

1.25

3.0

2.3

mmol/l

4.1

4.0

0.95

749

(3045683) HLA typing for celiac disease panel - Blood or Tissue

519

1.29

1.25

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

209

1816

1.15

1.25

2.8

3.2

mg/l

1.5

0.79

198

1682

(44806420)

158

0.51

1.24

2.3

2.4

—

(40758292) HTLV I+II Ab panel - Serum

118

0.42

1.24

1.8

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.22

1.24

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.86

1.23

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3042

29527

1.05

1.23

3.7

3.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

267

2362

1.13

1.23

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.00

1.23

4.1

7.3

—

(3052592) Norovirus Ag [Presence] in Stool

131

1.60

1.23

1.5

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

468

1.31

1.22

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

742

0.77

1.21

2.9

2.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.80

1.20

1.8

1.5

15.9

9.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

166

1422

1.17

1.20

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

461

1.30

1.20

2.0

1.5

ug/l

18.2

8.2

0.73

411

(3016018) Differential panel - Cerebral spinal fluid

104

854

1.22

1.19

1.5

1.4

—

(4306422)

150

1275

1.18

1.19

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.31

1.18

1.0

1.1

nmol/l

203.7

271.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.93

1.16

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

265

2354

1.13

1.16

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

131

1105

1.19

1.15

3.8

3.2

1.1

1.4

1.09

106

874

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

110

1.64

1.15

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

262

2330

1.13

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

554

1.27

1.13

1.2

—

(3019977) pH of Arterial blood

361

1.33

1.12

1.8

3.1

7.4

0.16

125

(3016750) Collection duration of Urine

370

1.33

1.12

1.9

2.2

min

488.5

499.8

0.43

281

(21494814) CD8 cells/100 lymphocytes in Specimen

318

0.66

1.11

1.5

2.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1586

15197

1.05

1.10

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

584

1.25

1.09

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

584

1.25

1.09

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

584

1.25

1.09

1.8

1.6

—

(3003181) Sodium [Moles/volume] in Urine

142

1214

1.17

1.08

1.3

1.4

mmol/l

69.0

63.9

0.65

106

972

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1807

17395

1.05

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

157

1359

1.16

1.03

1.0

1.1

u/ml

1.4

1.7

0.11

329

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.27

1.03

1.0

—

0.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.96

1.03

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

154

1.49

1.03

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.92

1.02

1.1

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

438

1.28

1.02

1.4

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

483

1.26

1.01

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

155

1.49

1.00

1.0

1.1

umol/24h

0.5

0.7

—

(3015183) Erythrocyte sedimentation rate

439

1.28

1.00

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.77

1.00

2.6

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.88

1.00

2.6

2.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

187

1646

1.14

0.99

1.1

u/ml

2.0

1.2

0.39

606

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.84

0.98

1.2

1.1

mmol/l

9.5

8.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

142

1226

1.16

0.98

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

105

884

1.19

0.98

1.1

91.4

95.1

0.93

835

(3034426) Prothrombin time (PT)

283

1.34

0.98

1.2

—

(3025130) Human papilloma virus identified in Specimen

170

1488

1.15

0.98

1.7

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.97

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.97

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.97

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.97

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

132

1.52

0.96

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

132

1.52

0.96

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

132

1.52

0.96

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

100

1.60

0.96

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

336

1.31

0.96

1.0

1.1

—

(3013862) HLA-DP [Type]

0.00

0.96

0.0

1.0

—

(40762814) Titanium [Mass/volume] in Blood

108

1.58

0.96

2.5

2.3

ug/l

7.6

4.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

487

1.25

0.95

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

416

1.28

0.95

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

168

1473

1.14

0.95

1.7

1.6

—

(3006462) Nitrate [Presence] in Urine

372

1.29

0.95

2.7

3.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

533

1.24

0.94

1.2

1.1

ratio

1.1

0.60

184

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

109

1.56

0.93

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

570

1.23

0.93

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

154

1345

1.15

0.92

1.1

au/ml

6.2

12.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

243

1.36

0.92

2.2

3.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

142

1.48

0.92

1.1

ug/l

79.0

76.5

0.08

123

(3023419) Bacteria identified in Sputum by Culture

101

854

1.18

0.91

3.0

2.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

508

1.24

0.91

2.3

2.8

e6/l

729.1

777.5

0.22

227

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

261

1.34

0.91

2.0

2.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

193

1715

1.13

0.90

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

177

1997

0.88

0.89

1.7

3.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

394

1.27

0.88

1.2

1.5

—

(3037121) Protein [Mass/volume] in Urine

268

2430

1.11

0.88

2.8

2.9

g/l

0.3

0.07

120

928

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

359

1.28

0.88

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

479

4459

1.08

0.88

1.4

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

211

1890

1.12

0.87

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

566

1.22

0.87

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

539

1.23

0.87

2.2

2.6

e6/l

448.9

534.3

1.07

449

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

449

1.25

0.86

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

2914

28444

1.04

0.86

2.7

2.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.82

0.85

1.3

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

477

1.24

0.85

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

523

1.23

0.84

2.3

2.6

e9/l

0.2

0.09

448

(1761482) Bacteria [#/volume] in Urine by Culture

147

1669

0.88

0.83

3.4

4.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1006

0.84

0.83

5.8

5.3

umol/l

373.8

368.7

0.14

875

(3042111) Morphology [Interpretation] in Bone marrow Narrative

121

1049

1.16

0.83

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

323

2967

1.09

0.83

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

188

1.38

0.82

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

301

1.30

0.82

2.6

3.4

—

(21494755) Public health laboratory ask at order entry panel

775

8163

0.94

0.81

1.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.88

0.81

1.0

1.1

—

(4133840)

189

0.63

0.81

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.70

0.80

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

102

876

1.17

0.80

2.5

—

(3022475) Manganese [Moles/volume] in Blood

1.72

0.79

1.2

—

(3044927) Protein electrophoresis panel - Urine

646

1.19

0.79

1.3

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

392

1.25

0.79

1.6

1.5

nmol/l

1.4

1.3

0.42

301

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

125

1092

1.15

0.78

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

177

1582

1.12

0.78

1.5

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

183

1639

1.12

0.78

1.3

1.4

u/l

28.5

29.5

0.14

150

1345

(3022621) pH of Urine by Test strip

538

5056

1.07

0.78

3.2

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

167

1490

1.12

0.77

2.7

2.4

ug/min

83.5

83.3

0.00

110

874

(4211845)

404

1.24

0.75

2.6

3.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

591

5581

1.06

0.75

2.9

3.4

u/ml

60.7

54.2

0.15

571

5383

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

817

1.16

0.75

1.2

—

(40768443) Skin Pathology biopsy report

370

3439

1.08

0.74

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

572

6057

0.94

0.74

2.8

2.5

ml/min/173m2

68.2

68.7

0.14

231

2350

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

387

1.24

0.74

1.9

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.84

0.73

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

689

1.18

0.73

1.4

mmol/l

12.7

11.8

0.35

143

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

402

0.77

0.73

1.4

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

219

1.33

0.73

1.6

2.1

e6/l

168.0

176.7

0.09

115

(3045142) Bone marrow Pathology biopsy report

708

1.17

0.72

1.2

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.75

0.71

1.0

u/l

26.7

52.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

1113

1.13

0.70

2.4

2.6

u/ml

406.3

1210.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

186

1.35

0.69

1.2

1.1

87.1

81.0

0.46

(3025315) Body weight

1.55

0.69

4.0

3.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

610

1.18

0.69

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

520

0.81

0.69

1.3

—

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

364

1.24

0.68

2.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

364

1.24

0.68

2.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

364

1.24

0.68

2.0

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

302

1.26

0.67

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

365

1.23

0.67

2.0

1.7

—

(3020650) Glucose [Presence] in Urine

215

0.70

0.67

1.1

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.63

0.66

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.63

0.66

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

136

1.40

0.66

2.2

2.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.79

0.66

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.79

0.66

1.2

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

1.79

0.66

1.4

2.0

mmol/l

27.0

17.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

294

1.26

0.66

2.2

1.9

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.51

0.66

9.6

12.0

mmol/l

5.4

5.2

0.14

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.51

0.66

1.2

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

614

1.17

0.65

1.3

1.5

—

(3024932) HLA-DR beta [Type]

215

1.30

0.64

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

154

1386

1.11

0.64

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

143

1282

1.12

0.64

1.3

1.4

ug/l

2.3

3.7

3.08

123

1118

(3028300) Cannabinoids [Presence] in Urine

276

2976

0.93

0.63

1.5

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

138

1237

1.12

0.62

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

766

1.15

0.62

11.8

5.1

mmol/l

7.3

7.5

0.16

638

(3017569) Oxygen content in Arterial blood

306

1.24

0.62

2.0

2.2

—

(40768793) Breast Pathology biopsy report

252

2332

1.08

0.60

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

196

1794

1.09

0.60

2.2

2.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.60

0.0

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

398

1.21

0.60

1.1

85.9

93.0

1.40

315

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.57

0.60

1.0

1.2

—

(3016038) Potassium [Moles/volume] in Urine

444

1.19

0.60

1.1

1.2

mmol/l

34.9

33.8

0.14

379

(43055514) Macroprolactin [Presence] in Serum or Plasma

218

1.29

0.60

1.1

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

142

1280

1.11

0.59

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

145

1309

1.11

0.59

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

290

1.24

0.59

2.2

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

290

1.24

0.59

2.2

1.9

—

(3027944) Amphetamines [Presence] in Urine

272

2924

0.93

0.59

1.5

2.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

201

1.29

0.58

1.6

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

145

1310

1.11

0.58

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

5.1

—

3.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

538

1.17

0.58

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.71

0.57

1.2

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

145

1312

1.11

0.57

1.3

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

763

1.14

0.57

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

670

1.15

0.56

4.1

3.2

57.5

56.8

0.10

446

(3024471) HLA-A [Type]

220

1.27

0.56

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.67

0.56

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.56

3.5

4.1

—

(3027008) Opiates [Presence] in Urine

277

2969

0.93

0.56

1.5

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

256

1.25

0.56

1.1

—

(3016879) Cocaine [Presence] in Urine

252

2710

0.93

0.56

1.5

2.1

—

(4198724)

319

0.78

0.56

1.8

3.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

185

1.30

0.56

1.6

1.3

36.3

37.1

0.04

125

(3008401) Mugwort IgE Ab [Units/volume] in Serum

156

1420

1.10

0.55

1.0

1.1

u/ml

0.7

1.1

1.04

558

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

275

1.24

0.55

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

248

1.25

0.55

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.50

0.54

5.1

2.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

255

2375

1.08

0.54

1.3

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

608

1.15

0.53

1.0

mg/l

308.4

294.1

0.90

544

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

254

2367

1.08

0.53

1.3

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

646

1.15

0.53

1.1

1.2

u/ml

93.3

59.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

169

1.30

0.53

1.6

1.5

2.4

3.1

0.20

143

(40765089) Chromosome analysis panel - Blood by G-banded

204

0.73

0.52

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

276

2948

0.93

0.52

1.5

2.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

255

2380

1.07

0.52

1.3

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.62

0.52

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

856

1.12

0.51

1.1

—

4.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

255

2382

1.07

0.51

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

342

1.20

0.51

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

342

1.20

0.51

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

233

1.25

0.50

1.1

—

(3000012) Reticulocyte production index

358

0.81

0.50

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

144

1.32

0.50

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

315

1.21

0.50

30.3

26.2

ug/l

120.5

114.1

0.24

262

(3051593) INR in Capillary blood by Coagulation assay

270

1.22

0.49

9.2

11.3

—

(3028707) Methadone [Presence] in Urine by Screen method

118

1302

0.91

0.49

1.6

2.8

—

(3051101) Glucose [Moles/volume] in Cord blood

108

0.65

0.48

3.9

6.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.52

0.48

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

172

1.28

0.48

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.49

0.47

5.4

5.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

522

1.15

0.47

1.0

u/ml

8.1

0.7

0.46

124

(3026470) Cobalt [Mass/volume] in Blood

401

1.17

0.47

2.1

2.0

ug/l

2.4

3.7

1.13

350

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

318

1.20

0.46

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

859

8311

1.04

0.46

1.6

—

(40768446) Kidney Pathology biopsy report

254

1.22

0.46

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

200

1.25

0.46

1.2

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

120

1.33

0.46

1.8

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.43

0.45

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.43

0.45

1.8

1.1

—

(4268621)

855

1.11

0.45

2.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

265

1.21

0.44

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

271

2554

1.06

0.44

1.4

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.37

0.43

5.2

4.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

148

1.28

0.43

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

202

1.24

0.43

1.6

1.5

58.5

61.5

0.13

167

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

193

1.24

0.43

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

161

1491

1.08

0.43

1.0

1.1

u/ml

3.2

4.9

1.13

742

(4027681)

508

1.14

0.43

1.3

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

151

0.73

0.42

2.0

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

396

1.16

0.42

2.0

2.8

42.9

41.2

0.25

143

(3012494) Peanut IgE Ab [Units/volume] in Serum

239

1.21

0.42

1.0

1.1

u/ml

0.2

1.4

1.67

128

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

322

1.18

0.42

1.6

2.2

umol/l

177.8

145.3

0.20

172

(3022689) Creatine [Moles/volume] in Urine

203

1.23

0.42

1.3

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

185

1.24

0.41

1.2

1.1

76.1

71.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

490

4703

1.04

0.41

1.6

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.52

0.41

7.6

9.2

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

12097.4

—

(3027874) Urate [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

250

0.80

0.41

1.4

2.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

351

1.17

0.41

3.7

2.2

ug/l

18.2

172.8

0.97

329

(3036180) Methadone [Presence] in Urine

0.00

0.40

0.0

3.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.40

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

473

1.14

0.40

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

138

0.72

0.40

1.3

2.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

108

987

1.10

0.40

1.3

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.40

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.40

0.0

2.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.43

0.39

1.6

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

452

4338

1.04

0.39

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

110

1008

1.09

0.39

1.3

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

2075

20401

1.02

0.39

4.1

estimate

0.0

2.37

780

7085

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

178

1.24

0.38

1.0

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

279

1.18

0.38

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1620

16519

0.98

0.38

4.0

4.1

kg/l

1.0

0.04

282

2508

(3024522) Salmonella sp identified in Specimen by Organism specific culture

108

990

1.09

0.38

1.3

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.39

0.38

1.2

1.9

—

(3000330) Specific gravity of Urine by Test strip

345

3612

0.95

0.37

2.9

3.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1030

0.91

0.37

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

144

1338

1.08

0.37

1.8

2.0

nmol/l

0.9

0.8

0.56

118

1142

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

1.23

0.37

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.35

0.37

1.4

1.7

umol/l

1.2

0.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.35

0.37

1.0

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

107

1.31

0.37

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

440

1.14

0.36

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

668

1.11

0.36

1.4

1.5

36.9

33.4

0.32

390

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.27

0.36

1.8

2.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

428

0.86

0.36

2.7

2.6

—

29.9

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

108

1.30

0.35

9.9

7.3

—

(4024509)

775

1.10

0.35

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.37

0.34

1.1

1.2

umol/24h

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

100

1.30

0.33

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

711

1.10

0.33

1.5

1.6

mmol/l

7.7

0.07

431

(3000285) Sodium [Moles/volume] in Blood

0.67

0.32

1.0

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

259

2469

1.05

0.32

2.2

1.9

ug/l

1.1

2.1

2.01

223

2186

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

204

1932

1.06

0.32

1.4

1.3

mg/l

473.8

498.2

0.43

194

1836

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.33

0.32

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

655

1.10

0.32

1.2

1.1

mg/l

41.3

39.5

0.10

549

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

391

0.87

0.31

1.8

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

128

1.25

0.31

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.30

0.31

1.0

—

(3011412) CD3 cells [#/volume] in Blood

761

1.09

0.31

2.1

2.4

e9/l

1.1

1.2

0.30

457

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

885

9058

0.97

0.30

7.3

6.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.31

0.30

3.7

2.5

u/field

0.6

0.8

0.13

(4146454)

706

1.09

0.30

3.1

2.6

—

(4281824)

1056

0.93

0.29

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

239

0.84

0.29

1.7

1.6

ug/l

8.9

8.7

0.07

239

(1001926) Buprenorphine [Presence] in Urine by Screen method

216

2268

0.95

0.29

1.6

2.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.29

1.3

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

332

3194

1.04

0.29

2.2

1.7

mg/l

3.3

3.6

0.32

259

2238

(4015189)

185

1.19

0.29

2.2

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

104

1116

0.93

0.28

1.0

1.1

u/ml

1.5

3.5

1.34

431

(3036670) Protein [Mass/volume] in Synovial fluid

204

1.18

0.28

1.3

1.2

g/l

42.2

38.0

0.84

109

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

298

1.14

0.28

3.1

4.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

216

0.83

0.28

1.3

53.6

49.5

0.15

182

(40765096) Chromosome analysis panel by Banding

183

0.82

0.27

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

904

8851

1.02

0.27

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

499

1.10

0.27

1.5

u/ml

24.7

20.3

—

109

(3001964) Herpes simplex virus Ag [Presence] in Specimen

234

1.15

0.26

1.5

1.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.25

0.25

1.2

1.0

—

3.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.25

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

799

0.93

0.25

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

416

1.11

0.24

2.7

1.7

u/field

1.4

2.9

1.41

297

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

637

1.08

0.24

1.1

mg/l

236.4

247.0

0.18

562

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

202

0.84

0.24

1.1

—

(3014891) Appearance of Pleural fluid

1.18

0.24

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

657

1.08

0.24

2.4

2.8

—

(3019174) dRVVT (LA screen)

1.28

0.24

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.28

0.24

1.4

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

224

2150

1.04

0.24

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

293

1.13

0.24

1.2

1.1

103.6

112.8

0.58

266

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

104

978

1.06

0.23

1.4

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

456

1.10

0.23

1.2

1.1

u/l

1.1

0.35

206

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.32

0.23

1.0

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

134

1.19

0.22

5.1

7.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

200

0.85

0.22

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

650

1.08

0.22

1.4

e6/l

212448.3

61754.5

0.65

449

(3005988) Vibrio sp identified in Specimen by Organism specific culture

104

980

1.06

0.22

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

385

3741

1.03

0.22

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.27

0.22

1.7

2.0

—

(3000034) Microalbumin [Mass/volume] in Urine

651

1.08

0.22

2.8

mg/l

26.9

38.9

0.37

466

(3025577) Chromium [Mass/volume] in Blood

391

1.10

0.21

2.4

2.0

ug/l

2.0

2.7

1.14

333

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

988

0.94

0.21

1.0

u/ml

0.2

0.4

0.55

199

(3004775) Volume in Urine collected for unspecified duration

497

1.09

0.21

2.2

624.5

637.0

0.09

344

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.1

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

382

1.10

0.21

1.1

1.4

nmol/l

130.8

134.3

0.25

382

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.21

0.0

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

166

1589

1.05

0.21

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1009

9929

1.02

0.21

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

621

6080

1.02

0.21

1.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

102

0.78

0.21

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

103

0.78

0.21

2.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

585

0.92

0.21

2.5

2.1

u/field

2.1

0.02

253

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

105

0.76

0.21

2.1

2.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.6

—

103.6

—

(40768800) Prostate Pathology biopsy report

666

0.93

0.20

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

108

1.20

0.20

1.7

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

840

1.06

0.19

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

113

1188

0.95

0.19

1.1

u/ml

3.0

3.4

0.10

435

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

568

1.07

0.19

1.6

2.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

103

977

1.05

0.19

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.22

0.19

4.5

7.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.15

0.19

2.5

3.2

g/mol

34.2

35.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

143

0.84

0.18

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

109

1.19

0.18

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

309

1.10

0.18

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

638

1.07

0.18

2.4

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

290

1.10

0.18

1.1

92.8

92.9

—

119

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

223

1.12

0.18

1.2

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.19

0.18

1.0

1.2

—

2.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

321

0.90

0.18

1.2

1.5

iu/ml

—

1901101.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

176

1696

1.04

0.18

1.4

1.2

mmol/l

3.8

3.7

0.58

167

1597

(3013637) Mi-2 Ab [Presence] in Serum

185

1.14

0.18

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

185

1.14

0.18

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

185

1.14

0.18

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

185

1.14

0.18

1.0

1.1

—

(3045716) Anion gap in Serum or Plasma

310

0.90

0.17

1.8

2.4

mmol/l

9.8

9.3

0.27

233

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

289

0.90

0.17

1.1

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.13

0.17

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.22

0.17

1.3

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

180

1738

1.04

0.17

3.1

3.7

u/ml

20.9

33.2

1.93

175

1682

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.11

0.17

1.0

1.1

—

(3048879) Bone marrow aspiration report

167

1.14

0.16

1.2

2.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

167

1.14

0.16

1.2

1.1

—

205.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

196

1.12

0.16

2.8

3.2

ng/l

57.6

127.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

185

1912

0.97

0.16

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

283

1.10

0.15

1.1

1.2

86.0

94.2

—

121

(44813793)

606

0.94

0.15

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

171

0.88

0.14

1.5

2.0

umol/l

19.8

17.1

0.30

171

(3042517) Benzodiazepines panel - Urine

0.80

0.14

1.4

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

498

1.06

0.14

1.4

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

304

1.09

0.14

1.1

ng/l

92.6

667.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

254

0.91

0.14

1.0

—

6.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

206

2003

1.03

0.14

1.4

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

160

0.87

0.14

1.1

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

501

0.94

0.14

1.6

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

160

1.13

0.14

1.2

—

(3044007) Cell count panel - Peritoneal fluid

189

1.11

0.13

1.6

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

549

1.06

0.13

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

113

1.15

0.13

2.3

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

903

9131

0.99

0.12

1.6

1.7

1.3

1.4

2.04

784

8090

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

248

1.09

0.12

1.2

10.8

19.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

142

1.13

0.12

1.8

2.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

104

1.15

0.12

1.1

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

152

1.12

0.12

1.3

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

502

1.06

0.12

1.5

1.4

mmol/l

5.8

5.7

0.31

475

(40768441) Liver Pathology biopsy report

581

1.05

0.11

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

649

0.96

0.11

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

125

1213

1.03

0.11

1.4

1.3

mmol/l

7.2

0.04

890

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

277

2823

0.98

0.11

2.1

1.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

134

1.12

0.10

1.3

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

115

1.13

0.10

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

446

1.05

0.10

1.8

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

372

0.94

0.10

1.4

3.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

199

1947

1.02

0.10

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

146

1424

1.03

0.09

2.9

3.3

u/ml

625.5

618.7

0.00

138

1294

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

418

1.05

0.09

1.1

u/ml

5.3

6.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

369

1.06

0.09

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

138

1415

0.97

0.09

1.3

—

(3005033) Fetal Nuchal fold Thickness US

198

1940

1.02

0.09

1.3

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.09

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

194

1.08

0.09

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

194

1.08

0.09

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

165

1.09

0.08

1.2

1.0

mg/g

7.9

6.6

0.29

156

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

814

1.03

0.08

1.7

2.1

32.6

0.02

807

(3037692) Legionella sp identified in Specimen by Organism specific culture

257

0.93

0.08

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

312

1.06

0.08

1.2

1.4

pmol/l

127.8

144.8

0.07

101

(3043409) Potassium [Moles/volume] in Arterial blood

194

1976

0.98

0.08

3.8

4.1

mmol/l

3.8

0.11

182

1859

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.08

0.08

1.0

—

(4212803)

1.08

0.08

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

760

7538

1.01

0.08

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.04

0.08

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

480

1.04

0.07

1.2

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

559

1.04

0.07

1.1

iu/ml

7.7

8.9

0.11

139

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.83

0.07

1.0

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

288

2920

0.99

0.07

1.3

miu/ml

256.6

230.0

0.61

150

1398

(40761539) Cells [Type] in Urine sediment by Light microscopy

174

0.92

0.07

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.04

0.07

1.3

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

108

1.11

0.07

1.2

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

112

0.89

0.07

1.3

1.2

u/ml

0.0

0.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.87

0.07

3.0

2.5

—

(3017509) Phencyclidine [Presence] in Urine

0.83

0.07

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

196

1.07

0.07

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

509

5137

0.99

0.07

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

118

1.10

0.07

4.5

7.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

265

0.94

0.07

2.8

2.9

umol/l

28.5

28.2

0.04

196

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.12

0.06

1.0

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

394

1.04

0.06

1.2

41.4

65.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

168

1.07

0.06

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

237

1.06

0.05

1.6

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

316

1.04

0.05

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

316

1.04

0.05

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

484

1.03

0.05

1.7

—

(40757373) Influenza virus identified in Isolate

139

1.08

0.05

1.1

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

198

1.06

0.05

1.1

u/ml

73.3

50.1

0.57

191

(3045424) Erythrocytes [Presence] in Urine

132

1342

0.98

0.05

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

232

0.95

0.05

1.6

2.2

e6/l

547.4

936.1

0.87

159

(21494815) CD4 cells/100 lymphocytes in Specimen

626

0.97

0.05

1.8

2.3

51.4

42.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

160

0.94

0.04

1.4

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

251

2488

1.01

0.04

1.6

iu/ml

0.2

8.8

0.70

528

(3033799) Differential panel - Peritoneal fluid

200

0.95

0.03

2.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

587

1.02

0.03

1.3

mmol/l

2.0

0.01

552

(3020891) Body temperature

264

2621

1.01

0.03

4.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

360

0.97

0.03

1.2

1.5

7.8

4.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

319

0.97

0.02

2.8

2.4

umol/l

46.5

52.8

0.84

261

(3020191) Ethanol [Moles/volume] in Serum or Plasma

530

1.02

0.02

1.2

1.5

promille

1.0

1.1

0.39

401

(40757494) Bilirubin.total [Moles/volume] in Blood

361

1.03

0.02

2.2

2.3

umol/l

12.9

19.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

356

3544

1.00

0.02

2.5

2.6

e6/l

0.2

0.3

0.17

348

3422

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

389

0.98

0.02

1.1

miu/ml

1636.1

1541.0

0.19

389

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

202

1.04

0.02

1.3

2.0

e6/l

18468.9

20172.4

—

107

(3015076) Soybean IgE Ab [Units/volume] in Serum

478

0.98

0.01

1.0

u/ml

0.1

1.5

—

(3045414) Leukocytes [Presence] in Urine

359

3582

1.00

0.00

1.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

234

1.03

0.00

3.5

3.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

516

0.99

0.00

1.3

1.4

nmol/l

19.9

31.2

3.00

463

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

606

0.99

0.00

1.6

2.1

14.0

13.7

0.12

278

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

103

0.97

0.00

5.3

2.6

—

(3024869) Neuronal Ab [Presence] in Serum

127

1.02

0.00

1.3

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

0.98

0.00

1.7

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

0.98

0.00

1.7

3.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

504

0.99

0.00

1.2

1.3

—

(44806071)

115

0.96

0.00

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

135

0.96

0.00

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

0.97

0.00

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

325

0.98

0.00

1.7

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

705

0.99

0.00

1.4

1.6

—

(3002619) Bacteria identified in Specimen by Culture

162

0.99

0.00

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

162

0.99

0.00

1.3

1.9

—

(3047189) Immunofixation for 24 hour Urine

288

1.01

0.00

2.4

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

491

1.00

0.00

1.2

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

619

1.00

0.00

1.6

2.1

72.7

73.9

0.36

594

(21494434) Karyotype in Bone marrow

531

1.00

0.00

1.1

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

111

0.99

0.00

2.0

2.7

—

23.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.90

0.00

1.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

30.4

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.98

0.00

1.0

1.1

u/l

47.3

9.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.98

0.00

2.4

2.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.93

0.00

1.0

—

(3001729) Color of Synovial fluid

0.98

0.00

1.3

1.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.8

—

(3024263) Appearance of Synovial fluid

370

1.00

0.00

2.1

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.98

0.00

1.2

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

3.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

2.5

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.92

0.00

1.1

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.98

0.00

1.4

3.1

—

0.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: GRAVES_COND – Carbimazole or st.post thyroidectomy, condition for graves disease

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Carbimazole or st.post thyroidectomy, condition for graves disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Carbimazole or st.post thyroidectomy, condition for graves disease (GRAVES_COND)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints